Mundipharma Diversifies Regional Portfolio at DUPHAT 2017

March 14, 2017 - 3 minutes read

Flagship brand Betadine® expands portfolio with Betadine® Intimate Cleanser and Betadine® Soothing Relief

Dubai, UAE, 14 March 2017 – Global pharmaceutical leader Mundipharma strengthened its regional presence with the launch of new offerings from flagship brand Betadine® on 8 March 2017 at the Dubai International Pharmaceutical and Technologies (DUPHAT) Conference 2017. The new additions to its healthcare portfolio includes the Betadine® Intimate Cleanser Range and Betadine® Soothing Relief Range.

Speaking at the exhibition & conference, Dr. Ashraf Allam, Regional Vice President of Mundipharma Middle East and Africa commented, “We have seen rapid growth across the Middle East, and are expanding our footprint in specialty healthcare to offer patients a range of treatment solutions for allergy relief and feminine care. DUPHAT remains a significant platform to showcase our advancements in pharmaceutical technology.”

Mundipharma presented the Betadine® Soothing Relief Range for allergy symptoms relief developed with natural ingredient Ectoin®, applied to relieve nasal and sinus allergies, eye allergies and inhalation solutions. The three pharmaceutical treatments will be available at leading pharmacies across the UAE for over the counter purchase.

Mundipharma has also expanded their feminine healthcare portfolio from existing therapeutic treatment to preventative care, with the Betadine® Intimate Cleanser Range. The dermatologically tested products include an intimate wash and intimate foam that are soap, paraben and colorant free, featuring natural Tri-Care Formulation and Prebiotics to offer gentle care for women’s daily hygiene needs. The Intimate Care Range will be available for purchase at leading pharmacies and supermarkets across the UAE.

Mundipharma was exhibiting at DUPHAT 2017 at the Hall 8, Dubai International Convention and Exhibition Centre from the 7th to 9th March 2017.

-END –


About Mundipharma

Mundipharma and its network of privately owned Independent Associated Companies (IACs) is dedicated to alleviating human suffering and improving quality of life for the human race. The Mundipharma story, spanning over six decades brings together a visionary approach and a pioneering spirit – what is best told through its patients, employees and the communities across six continents in which they serve. Mundipharma is focused on business transformation by leveraging global leadership in pain and, through a shared spirit of innovation, building a growing presence in antisepsis, respiratory, oncology, ophthalmology, consumer healthcare and other specialty areas.

For more information, please visit:

Mundipharma MEA
Patrycja Czoch, Manager, Corporate Communications
Mob: +97 1 50 85 12 700